RING1 and myelodysplastic syndrome: Our results indicate that the capacity of RING1A to inhibit differentiation in vitro is also reflected in MDS patients where higher RING1A levels correlated with a higher number of dysplastic lineages, and thus likely a higher number of cytopenias and greater severity of the disease.